Cell Source, Inc. (CLCS)

Cell Source Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.02	0.02	0.22	0.09	0.24	0.03
Cash & Short-Term Investments	0.02	0.02	0.22	0.09	0.24	0.03
Cash Growth	790.47%	-90.03%	139.18%	-61.47%	765.77%	47.40%
Prepaid Expenses	0.24	0.16	0.16	0.2	0.18	0.06
Other Current Assets	0	0.01	0.02	0.02	0.03	0.03
Total Current Assets	0.26	0.2	0.41	0.31	0.45	0.11
Other Long-Term Assets	-	-	-	-	0	-
Total Assets	0.26	0.2	0.41	0.31	0.45	0.11
Accounts Payable	2.04	1.47	0.68	0.22	0.19	0.14
Accrued Expenses	5.53	4.75	4.22	3.12	3.08	2.42
Short-Term Debt	9.11	8.22	7	4.66	3.31	1.59
Current Portion of Long-Term Debt	0.99	1.08	0.91	1.83	1.49	0.97
Other Current Liabilities	1.55	0.29	0.24	0.3	0.32	0.6
Total Current Liabilities	19.21	15.81	13.04	10.14	8.4	5.71
Long-Term Debt	-	-	-	-	-	0.15
Total Liabilities	19.21	15.81	13.04	10.14	8.4	5.86
Common Stock	0.04	0.04	0.04	0.03	0.03	0.03
Additional Paid-In Capital	26.86	26.01	23.67	21.32	17.72	15.38
Retained Earnings	-45.85	-41.67	-36.35	-31.18	-25.71	-21.15
Total Common Equity	-18.94	-15.61	-12.64	-9.83	-7.95	-5.74
Shareholders' Equity	-18.94	-15.61	-12.63	-9.83	-7.95	-5.74
Total Liabilities & Equity	0.26	0.2	0.41	0.31	0.45	0.11
Total Debt	10.1	9.3	7.9	6.5	4.81	2.7
Net Cash (Debt)	-10.07	-9.27	-7.68	-6.4	-4.56	-2.67
Net Cash Per Share	-0.25	-0.25	-0.22	-0.19	-0.16	-0.09
Filing Date Shares Outstanding	43.47	41.02	38.16	34.44	32.66	27.08
Total Common Shares Outstanding	43.25	39.83	36.08	34.36	32.54	27.08
Working Capital	-18.94	-15.61	-12.63	-9.83	-7.95	-5.6
Book Value Per Share	-0.44	-0.39	-0.35	-0.29	-0.24	-0.21
Tangible Book Value	-18.94	-15.61	-12.64	-9.83	-7.95	-5.74
Tangible Book Value Per Share	-0.44	-0.39	-0.35	-0.29	-0.24	-0.21

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.